The Polycystic Ovarian Syndrome Market is experiencing steady growth, driven by the increasing global prevalence of PCOS and a growing focus on women's health. Valued at USD 5.50 billion in 2024, the market is projected to reach USD 10.13 billion by 2035, registering a CAGR of 5.61%. This expansion is fueled by rising awareness, improved diagnostic capabilities, and the expanding...